Invivyd, Inc. (IVVD)
0.9274
-0.09
(-9.08%)
USD |
NASDAQ |
Sep 22, 12:04
Invivyd Market Cap : 273.36M for Sept. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 300.65M |
| September 18, 2026 | 222.63M |
| September 17, 2026 | 219.95M |
| September 16, 2026 | 237.37M |
| September 15, 2026 | 244.65M |
| September 14, 2026 | 262.86M |
| September 11, 2026 | 231.53M |
| September 10, 2026 | 228.70M |
| September 09, 2026 | 235.01M |
| September 08, 2026 | 243.41M |
| September 04, 2026 | 243.47M |
| September 03, 2026 | 246.12M |
| September 02, 2026 | 236.98M |
| September 01, 2026 | 259.36M |
| August 31, 2026 | 281.46M |
| August 28, 2026 | 284.29M |
| August 27, 2026 | 265.31M |
| August 26, 2026 | 265.78M |
| August 25, 2026 | 276.69M |
| August 24, 2026 | 277.81M |
| August 21, 2026 | 293.72M |
| August 20, 2026 | 280.25M |
| August 19, 2026 | 282.82M |
| August 18, 2026 | 255.88M |
| August 17, 2026 | 218.27M |
| Date | Value |
|---|---|
| August 14, 2026 | 212.49M |
| August 13, 2026 | 202.11M |
| August 12, 2026 | 215.76M |
| August 11, 2026 | 202.64M |
| August 10, 2026 | 190.36M |
| August 07, 2026 | 209.27M |
| August 06, 2026 | 186.37M |
| August 05, 2026 | 170.93M |
| August 04, 2026 | 162.10M |
| August 03, 2026 | 155.99M |
| July 31, 2026 | 151.30M |
| July 30, 2026 | 164.48M |
| July 29, 2026 | 153.56M |
| July 28, 2026 | 167.79M |
| July 27, 2026 | 172.48M |
| July 24, 2026 | 172.91M |
| July 23, 2026 | 172.28M |
| July 22, 2026 | 175.37M |
| July 21, 2026 | 192.79M |
| July 20, 2026 | 193.81M |
| July 17, 2026 | 209.98M |
| July 16, 2026 | 222.82M |
| July 15, 2026 | 231.05M |
| July 14, 2026 | 226.47M |
| July 13, 2026 | 222.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 367.77M |
| Amgen, Inc. | 218.80B |
| Anika Therapeutics, Inc. | 279.44M |
| BioCryst Pharmaceuticals, Inc. | 2.277B |
| Imunon, Inc. | 7.092M |
Market Cap Related Metrics
| PS Ratio | 4.299 |
| Price to Book Value | 1.510 |
| Price | 0.9274 |
| Earnings Yield | -40.22% |